Home>Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis
Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis
- Impact factors: 17.694
- Publication: Nature Communications
- Author:Yan Hao, Wu Wentong, Hu Yuhuai, Li Jinjin, Xu Jiangxin, Chen Xueqin, Xu Zhifei, Yang Xiaochun, Yang Bo, He Qiaojun, Luo Peihua
- DOI citation-doi:10.1038/s41467-023-38430-8
- Date:2023-05-13